These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 9595829

  • 1. [The solubility and in vivo-in vitro correlation of naltrexone].
    Navarro Guerrero J, Ruiz Ramirez JC, Lorduy Oses L.
    Boll Chim Farm; 1998 Jan; 137(1):16-20. PubMed ID: 9595829
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A 'biorelevant' system to investigate in vitro drug released from a naltrexone implant.
    Iyer SS, Barr WH, Dance ME, Coleman PR, Karnes HT.
    Int J Pharm; 2007 Aug 01; 340(1-2):104-18. PubMed ID: 17482393
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. Part 5: In vitro/in vivo correlation for chlorpromazine hydrochloride tablets.
    Ammar HO, Khalil RM, Omar SM.
    Pharmazie; 1993 Dec 01; 48(12):932-5. PubMed ID: 8115438
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a potential medium for 'biorelevant' in vitro release testing of a naltrexone implant, employing a validated stability-indicating HPLC method.
    Iyer SS, Barr WH, Karnes HT.
    J Pharm Biomed Anal; 2007 Feb 19; 43(3):845-53. PubMed ID: 17045445
    [Abstract] [Full Text] [Related]

  • 8. Comparative bioavailability and in vitro in vivo correlation of two sustained release brands of theophylline: tablets and pellets.
    Tulain U, Ur-Rahman N.
    Pak J Pharm Sci; 2008 Apr 19; 21(2):131-8. PubMed ID: 18390443
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Correlation between in vitro and in vivo parameters of commercial paracetamol tablets.
    Babalola CP, Oladimeji FA, Femi-Oyewo MN.
    Afr J Med Med Sci; 2001 Dec 19; 30(4):275-80. PubMed ID: 14510103
    [Abstract] [Full Text] [Related]

  • 11. In-vitro and in-vivo correlation for two gliclazide extended-release tablets.
    Mandal U, Ray KK, Gowda V, Ghosh A, Pal TK.
    J Pharm Pharmacol; 2007 Jul 19; 59(7):971-6. PubMed ID: 17637192
    [Abstract] [Full Text] [Related]

  • 12. In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs.
    Valiveti S, Hammell DC, Paudel KS, Hamad MO, Crooks PA, Stinchcomb AL.
    J Control Release; 2005 Feb 02; 102(2):509-20. PubMed ID: 15653167
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design.
    Giannola LI, De Caro V, Giandalia G, Siragusa MG, Tripodo C, Florena AM, Campisi G.
    Eur J Pharm Biopharm; 2007 Sep 02; 67(2):425-33. PubMed ID: 17451927
    [Abstract] [Full Text] [Related]

  • 15. Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice.
    He GA, Hou HM, Liu XJ.
    Acta Pharmacol Sin; 2001 Jun 02; 22(6):530-3. PubMed ID: 11747760
    [Abstract] [Full Text] [Related]

  • 16. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
    Dunbar JL, Turncliff RZ, Dong Q, Silverman BL, Ehrich EW, Lasseter KC.
    Alcohol Clin Exp Res; 2006 Mar 02; 30(3):480-90. PubMed ID: 16499489
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.